title: Advances in the treatment of chronic inflammatory demyelinating neuropathies in 2010.
abstract: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an uncommon disease of the peripheral nerves. The diagnosis is based mainly on clinical presentation, cerebrospinal fluid (CSF) examination, and electrodiagnostic studies. Treatment of CIDP has at least two components: supportive care and specific therapy including primarily steroids, intravenous immunoglobulins (IVIg), and plasmapheresis (PE). This review summarizes progress in the treatment of CIDP published during the last year.
authors.affiliation: Department of Neurology, Bicêtre University Hospital, AP-HP, 94275 Paris, France. pierre.lozeron@bct.aphp.fr
authors.forename: P
authors.initials: P
authors.lastname: Lozeron
authors.forename: D
authors.initials: D
authors.lastname: Adams
mesh_terms: D004568:Electrodiagnosis / Q000639:trends*; D006801:Humans; D018836:Inflammation Mediators / Q000134:cerebrospinal fluid / Q000191:economics / Q000627:therapeutic use*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy*
chemical_list: D018836:Inflammation Mediators